Skip to main content
Log in

Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The serum levels and the half life of ampicillin derived from Hetacillin after administration of the latter to a total of 61 rats classified in 7 groups were determined. Each of these groups was pre-treated for 15 days with the following inducers ; phenobarbital, diphenylhydantoin, diazepam, chlorpromazine and phenylbutazone. The control group received saline. The d-glucaric acid concentrat ion in the urine prior to and after the administration of inducers and the liver weight were taken as enzyme induction indices.

Results showed a positive correlation between the indices of induction and the levels of ampicillin originating from hetacillin with a significant correlation coefficient between the serum levels of ampicillin and urine d-glucaric acid for all drugs studied.

The different effect of the various drugs indicated that they could be classified into the following two groups : a) those that induced a significant increase of the levels and half life (t1/2) of ampicillin. The effect was significant in decreasing order for phenylbutazone (r = 0,990), diazepam (r = 0,990) and diphenylhydantoin (r = 0,753). b) those which initially resulted in a significant increase of the levels of ampicillin and thereafter in a decrease with a significant shortening of its V/2 too. The effect was most significant for phenobarbital (r = 0,887) and less so for chlorpromazine (r = 0,800). Only for these two drugs was a significant and actually negative correlation observed between d-glucaric acid and tl/2 that is : phenobarbital (r = − 0,967) chorpromazine (r = − 0,752). Results suggest an interaction of Hetacillin and the above inducers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Conney A.H. (1967): Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews,79, 317–366.

    Google Scholar 

  2. Marshall W.J. (1978): Enzyme induction by drugs. Its relevance to clinical biochemistry. Annals of Clinical Biochemistry,15, 55–64.

    CAS  PubMed  Google Scholar 

  3. Busfield D., Child K.J. and Tomich E.G. (1964): An effect of phenobarbitone on griseofulvin metabolism in the rat. British Journal of Pharmacology and Chemotherapy,22, 137–142.

    CAS  PubMed  Google Scholar 

  4. Neuvonen P.J. and Penttilä O. (1974): Interaction between Doxycycline and Barbiturates. British Medical Journal,1, 535–536.

    Article  CAS  PubMed  Google Scholar 

  5. Penttila O., Neuvonen P.J., Aho K. and Lehtovaara (1974): Interaction between Doxycycline and some antiepileptic drugs. British Medical Journal,2, 470–472.

    Article  CAS  PubMed  Google Scholar 

  6. Schwartz G.J., Hegyi T. and Spitzer A. (1976): Subtherapeutic dicloxacillin levels in aneonate: possible mechanisms. The Journal of Pediatrics,89, 310–312.

    Article  CAS  PubMed  Google Scholar 

  7. Goodman L.S. and Gilmann A. (1975): “The Pharmacological Basis of Therapeutics”, 5th edition, MacMillan publishing Co., Inc., New York.

    Google Scholar 

  8. Remmer H. (1970): The role of the liver in drug metabolism. The Americal Journal of Medicine,49, 617–629.

    Article  CAS  Google Scholar 

  9. Nishida M., Murakawa T., Mine Y., Fukada S., Kono Y. and Sueda Y. (1971): Studies on the formation and the activity of the transformation product of ampicillin. The Journal of Antibiotics,24, 641–646.

    CAS  PubMed  Google Scholar 

  10. Galanopoulou P., Karageorgiou Ch., Couvaris M. and Varonos D. (1980): Influence on liver enzyme induction caused by Phenobarbital in the biotransformation of hetacillin in male rats. Journal of Antimicrobial Chemotherapy. (Correspondence),6, 157–159.

    Article  Google Scholar 

  11. Silvestrini B., Catanese B. and Del-Basso P. (1966): Researches on the increase of liver weight produced by some drugs. Biochemical Pharmacology,15, 249–254.

    Article  CAS  PubMed  Google Scholar 

  12. Sotaniemi E.A., Madzihradsky F. and Elliason G. (1974): Glucaric acid as an indicator of use of enzyme inducing drugs. Clinical Pharmacology and Therapeutics,75, 417–423.

    Google Scholar 

  13. Remmer H. and Merker H.J. (1963): Drug-induced changes in the liver endoplasmic reticulum: association with drug-metabolizing enzymes. Science (New York),142, 1657–1658.

    CAS  Google Scholar 

  14. Hunter J., Carella M., Maxwell J.D., Stewart D.A. and Williams R. (1971): Urinary D-glucaric acid excretion as a test for hepatic enzyme induction in man. Lancet,1, 572–575.

    Article  CAS  PubMed  Google Scholar 

  15. Sellaman R., Kanto J., Raijola E. and Perkarinen A. (1975): Induction effect of Diazepam on its own metabolism. Acta Pharmacol. Toxicol.,37, 345–351.

    Google Scholar 

  16. Breyer U. (1972): Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism. Nauyn-Schmiedeberg’s Arch. Pharmacol.,272, 277–288.

    Article  CAS  Google Scholar 

  17. Piatt D.S. and Cockrill B.L. (1969): Biochemical changes in rat liver in response to treatment with drugs a n d other agents. I. effects of anticovulsant, anti-inflammatory, hypchlolesterolaemic and adrenergic b-blocking agents. Biochemical Pharmacology,18, 429–444.

    Article  Google Scholar 

  18. Bennet J.V., Brodie J.L., Benner E.J. and Kirby W.M. (1966): Simplified accurate method for antibiotic assay of clinical Specimens. Applied Microbiology,14, 170–177.

    Google Scholar 

  19. Marsh C.A. (1963): Metabolism of D-glucuronolactone in mamalian systemes. Identification of D-glucaric acid as a normal constituent of urine. Journal Biochemistry,86, 77–86.

    CAS  Google Scholar 

  20. Downie N.M. and Heath R.W. (1976): “Basic Statistical Methods ” . 4th ed. by Harper and Row Publishers.

  21. Kunin C.M. (1966): Clinical Pharmacology of the new penicillins. I. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clinical Pharmacology and Therapeutics,7, 166–179.

    CAS  PubMed  Google Scholar 

  22. Hartshorn E.A. (1969): Drug Intell.,3, 130.

    Google Scholar 

  23. Wilkinson G.R. and Schenker S. (1975): Drug disposition and liver disease. Drug Metabolism Reviews,4 (2), 139–175.

    Article  CAS  PubMed  Google Scholar 

  24. Kind A.C., Beaty H.N., Frederich F.L. and Kirby W.M.M. (1968): Inactivation of penicillins by the isolated rat liver. Journal Laboratory and Clinical Medicine,71, 728–735.

    CAS  Google Scholar 

  25. Breckenridge A., Davies D.S., Davies L. and Orme M. (1973): Dose dependant enzyme induction. British Journal of Pharmacology,47, 616–617.

    Google Scholar 

  26. Kirby W.M.M. and Kind A.C. (1967): Clinical Pharmacology of ampicillin and hetacillin. Anual New York Academic Science,145, 291–297.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couvaris, M., Galanopoulou, P., Karageorgiou, C. et al. Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties. European Journal of Drug Metabolism and Pharmacokinetics 10, 27–32 (1985). https://doi.org/10.1007/BF03189694

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189694

Key-words

Navigation